Matrix Capital Management Company, LP - Insider Trading & Ownership

Location
3 Pleasant Street, Suite 400, C/O Matrix Capital Management, Portsmouth, NH
Summary
The estimated value of insider holdings of Matrix Capital Management Company, LP is at least $206M dollars as of November 9, 2023. Matrix Capital Management Company, LP is the 10%+ Owner of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $144M. Matrix Capital Management Company, LP is the 10%+ Owner of Aura Biosciences, Inc. and owns shares of Aura Biosciences, Inc. (AURA) stock worth about $62.3M.
Signature
Matrix Capital Management Company, LP, by: /s/ David E. Goel, its Managing General Partner
All Insider Reports
All Insider Reports

Ownership of Matrix Capital Management Company, LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. 10%+ Owner $144M Jun 20, 2023
AURA Aura Biosciences, Inc. 10%+ Owner $62.3M Nov 9, 2023

Insider Transactions Reported by Matrix Capital Management Company, LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.